Naveen Chaudhary
Chandigarh, CH 160012, India
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Phage endolysin therapy: a modern antimicrobial strategy against highly drug-resistant superbugs.
Journal: Archives of microbiology
Published: October 14, 2025
In vitro and In vivo evaluation of phage-antibiotic synergy for the treatment of urinary tract infections.
Journal: Microbial pathogenesis
Published: February 23, 2025
Unveiling the Virtual Blueprint: Exploring the Structural and Functional Analysis of a Novel Endolysin LysSM5 Derived from Salmonella phage vB_SenA_SM5.
Journal: Indian journal of microbiology
Published: August 16, 2024
CRISPR-Cas-assisted phage engineering for personalized antibacterial treatments.
Journal: Indian journal of medical microbiology
Published: August 14, 2024
Phenotypic and genomic characterization of a small colony variant of Klebsiella pneumoniae isolated from urine of a prostate cancer case.
Journal: Indian journal of medical microbiology
Published: February 10, 2024
Computational Guided Drug Targets Identification against Extended-Spectrum Beta-Lactamase-Producing Multi-Drug Resistant Uropathogenic Escherichia coli.
Journal: Biomedicines
Published: June 28, 2023
Vibrio Phage VMJ710 Can Prevent and Treat Disease Caused by Pathogenic MDR V. cholerae O1 in an Infant Mouse Model.
Journal: Antibiotics (Basel, Switzerland)
Published: May 28, 2023
In Vitro and In Vivo Studies of Heraclenol as a Novel Bacterial Histidine Biosynthesis Inhibitor against Invasive and Biofilm-Forming Uropathogenic Escherichia coli.
Journal: Antibiotics (Basel, Switzerland)
Published: December 08, 2022
Genome Analysis and Antibiofilm Activity of Phage 590B against Multidrug-Resistant and Extensively Drug-Resistant Uropathogenic Escherichia coli Isolates, India.
Journal: Pathogens (Basel, Switzerland)
Published: August 15, 2022
Complete Genome Sequence of Salmonella Phage vB_SenA_SM5, Active against Multidrug-Resistant Salmonella enterica Serovar Typhi Isolates.
Journal: Microbiology resource announcements
Published: June 15, 2022
Repurposing of FDA approved drugs against uropathogenic Escherichia coli: In silico, in vitro, and in vivo analysis.
Journal: Microbial pathogenesis
Published: November 11, 2021
Whole genome sequencing and in vitro activity data of Escherichia phage NTEC3 against multidrug-resistant Uropathogenic and extensively drug-resistant Uropathogenic E. coli isolates.
Journal: Data in brief
Published: November 01, 2021
Last Updated: 09/26/2026